3731
Communiqué de presse
Revue 2024 des hypothèses L&H achevée, ratio de solvabilité Groupe de 203 %
Articles d'experts
12 novembre 2024
How consumer groups, patient representatives, and the insurance industry are working in partnership to help protect cancer survivors
Articles d'experts
31 octobre 2024
Using Pandemic Mortality Experience for Pricing Longevity
Actualités
25 octobre 2024
Winner of the 2024 Most Innovative Product/Service Award - General Insurance
L&H
campus
Drugs developed for the treatment of diabetes such as semaglutide (marketed as Ozempic or Wegovy), liraglutide (Saxenda), and tirzepatide (Mounjaro or Zepbound) are being used to decrease the weight of obesity risks:
